The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Platform Market Research Report 2024
Synopsis
Exosomes are present in all body fluids under both normal and pathophysiological conditions. Exosomes are extracellular vesicles (EVs) with a size range of ~40 to 160 nm (average ~100 nm) in diameter with an endosomal origin. Depending on the cell of origin, exosomes can contain many constituents of a cell, including DNA, RNA, lipids, metabolites, and cytosolic and cell-surface proteins. The physiological purpose of generating exosomes remains largely unknown and needs investigation. Intercellular communication through exosomes seems to be involved in the pathogenesis of various disorders, including cancer, neurodegeneration, and inflammatory diseases.
Global Exosome Platform market is projected to reach US$ 2784.9 million in 2029, increasing from US$ 1326 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Exosome Platform market research.
Key companies engaged in the Exosome Platform industry include Exosome Diagnostics, Lifeasible, Creative Bioarray, ReNeuron, Evox Therapeutics, Everzom, LipExoGen Biotech, Immunostep Biotech and AMSBIO, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Exosome Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Exosome Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Exosome Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exosome Diagnostics
Lifeasible
Creative Bioarray
ReNeuron
Evox Therapeutics
Everzom
LipExoGen Biotech
Immunostep Biotech
AMSBIO
Frontage Labs
System Biosicences (SBI)
RoosterBio
Clara Biotech
Luminous BioSciences
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology
Segment by Type
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Exosome Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Exosomes are present in all body fluids under both normal and pathophysiological conditions. Exosomes are extracellular vesicles (EVs) with a size range of ~40 to 160 nm (average ~100 nm) in diameter with an endosomal origin. Depending on the cell of origin, exosomes can contain many constituents of a cell, including DNA, RNA, lipids, metabolites, and cytosolic and cell-surface proteins. The physiological purpose of generating exosomes remains largely unknown and needs investigation. Intercellular communication through exosomes seems to be involved in the pathogenesis of various disorders, including cancer, neurodegeneration, and inflammatory diseases.
Global Exosome Platform market is projected to reach US$ 2784.9 million in 2029, increasing from US$ 1326 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Exosome Platform market research.
Key companies engaged in the Exosome Platform industry include Exosome Diagnostics, Lifeasible, Creative Bioarray, ReNeuron, Evox Therapeutics, Everzom, LipExoGen Biotech, Immunostep Biotech and AMSBIO, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Exosome Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Exosome Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Exosome Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exosome Diagnostics
Lifeasible
Creative Bioarray
ReNeuron
Evox Therapeutics
Everzom
LipExoGen Biotech
Immunostep Biotech
AMSBIO
Frontage Labs
System Biosicences (SBI)
RoosterBio
Clara Biotech
Luminous BioSciences
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology
Segment by Type
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Exosome Platform report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Exosome Isolation
1.2.3 Exosome Identification
1.2.4 Exosome Analysis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Exosome Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Company
1.3.4 Hospitals and Clinical
1.3.5 Testing Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Platform Market Perspective (2018-2029)
2.2 Exosome Platform Growth Trends by Region
2.2.1 Global Exosome Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Exosome Platform Historic Market Size by Region (2018-2023)
2.2.3 Exosome Platform Forecasted Market Size by Region (2024-2029)
2.3 Exosome Platform Market Dynamics
2.3.1 Exosome Platform Industry Trends
2.3.2 Exosome Platform Market Drivers
2.3.3 Exosome Platform Market Challenges
2.3.4 Exosome Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Platform Players by Revenue
3.1.1 Global Top Exosome Platform Players by Revenue (2018-2023)
3.1.2 Global Exosome Platform Revenue Market Share by Players (2018-2023)
3.2 Global Exosome Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Platform Revenue
3.4 Global Exosome Platform Market Concentration Ratio
3.4.1 Global Exosome Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Platform Revenue in 2022
3.5 Exosome Platform Key Players Head office and Area Served
3.6 Key Players Exosome Platform Product Solution and Service
3.7 Date of Enter into Exosome Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Platform Breakdown Data by Type
4.1 Global Exosome Platform Historic Market Size by Type (2018-2023)
4.2 Global Exosome Platform Forecasted Market Size by Type (2024-2029)
5 Exosome Platform Breakdown Data by Application
5.1 Global Exosome Platform Historic Market Size by Application (2018-2023)
5.2 Global Exosome Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Exosome Platform Market Size (2018-2029)
6.2 North America Exosome Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Exosome Platform Market Size by Country (2018-2023)
6.4 North America Exosome Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Platform Market Size (2018-2029)
7.2 Europe Exosome Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Exosome Platform Market Size by Country (2018-2023)
7.4 Europe Exosome Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Platform Market Size (2018-2029)
8.2 Asia-Pacific Exosome Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Exosome Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific Exosome Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Platform Market Size (2018-2029)
9.2 Latin America Exosome Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Exosome Platform Market Size by Country (2018-2023)
9.4 Latin America Exosome Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Platform Market Size (2018-2029)
10.2 Middle East & Africa Exosome Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Exosome Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa Exosome Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exosome Diagnostics
11.1.1 Exosome Diagnostics Company Detail
11.1.2 Exosome Diagnostics Business Overview
11.1.3 Exosome Diagnostics Exosome Platform Introduction
11.1.4 Exosome Diagnostics Revenue in Exosome Platform Business (2018-2023)
11.1.5 Exosome Diagnostics Recent Development
11.2 Lifeasible
11.2.1 Lifeasible Company Detail
11.2.2 Lifeasible Business Overview
11.2.3 Lifeasible Exosome Platform Introduction
11.2.4 Lifeasible Revenue in Exosome Platform Business (2018-2023)
11.2.5 Lifeasible Recent Development
11.3 Creative Bioarray
11.3.1 Creative Bioarray Company Detail
11.3.2 Creative Bioarray Business Overview
11.3.3 Creative Bioarray Exosome Platform Introduction
11.3.4 Creative Bioarray Revenue in Exosome Platform Business (2018-2023)
11.3.5 Creative Bioarray Recent Development
11.4 ReNeuron
11.4.1 ReNeuron Company Detail
11.4.2 ReNeuron Business Overview
11.4.3 ReNeuron Exosome Platform Introduction
11.4.4 ReNeuron Revenue in Exosome Platform Business (2018-2023)
11.4.5 ReNeuron Recent Development
11.5 Evox Therapeutics
11.5.1 Evox Therapeutics Company Detail
11.5.2 Evox Therapeutics Business Overview
11.5.3 Evox Therapeutics Exosome Platform Introduction
11.5.4 Evox Therapeutics Revenue in Exosome Platform Business (2018-2023)
11.5.5 Evox Therapeutics Recent Development
11.6 Everzom
11.6.1 Everzom Company Detail
11.6.2 Everzom Business Overview
11.6.3 Everzom Exosome Platform Introduction
11.6.4 Everzom Revenue in Exosome Platform Business (2018-2023)
11.6.5 Everzom Recent Development
11.7 LipExoGen Biotech
11.7.1 LipExoGen Biotech Company Detail
11.7.2 LipExoGen Biotech Business Overview
11.7.3 LipExoGen Biotech Exosome Platform Introduction
11.7.4 LipExoGen Biotech Revenue in Exosome Platform Business (2018-2023)
11.7.5 LipExoGen Biotech Recent Development
11.8 Immunostep Biotech
11.8.1 Immunostep Biotech Company Detail
11.8.2 Immunostep Biotech Business Overview
11.8.3 Immunostep Biotech Exosome Platform Introduction
11.8.4 Immunostep Biotech Revenue in Exosome Platform Business (2018-2023)
11.8.5 Immunostep Biotech Recent Development
11.9 AMSBIO
11.9.1 AMSBIO Company Detail
11.9.2 AMSBIO Business Overview
11.9.3 AMSBIO Exosome Platform Introduction
11.9.4 AMSBIO Revenue in Exosome Platform Business (2018-2023)
11.9.5 AMSBIO Recent Development
11.10 Frontage Labs
11.10.1 Frontage Labs Company Detail
11.10.2 Frontage Labs Business Overview
11.10.3 Frontage Labs Exosome Platform Introduction
11.10.4 Frontage Labs Revenue in Exosome Platform Business (2018-2023)
11.10.5 Frontage Labs Recent Development
11.11 System Biosicences (SBI)
11.11.1 System Biosicences (SBI) Company Detail
11.11.2 System Biosicences (SBI) Business Overview
11.11.3 System Biosicences (SBI) Exosome Platform Introduction
11.11.4 System Biosicences (SBI) Revenue in Exosome Platform Business (2018-2023)
11.11.5 System Biosicences (SBI) Recent Development
11.12 RoosterBio
11.12.1 RoosterBio Company Detail
11.12.2 RoosterBio Business Overview
11.12.3 RoosterBio Exosome Platform Introduction
11.12.4 RoosterBio Revenue in Exosome Platform Business (2018-2023)
11.12.5 RoosterBio Recent Development
11.13 Clara Biotech
11.13.1 Clara Biotech Company Detail
11.13.2 Clara Biotech Business Overview
11.13.3 Clara Biotech Exosome Platform Introduction
11.13.4 Clara Biotech Revenue in Exosome Platform Business (2018-2023)
11.13.5 Clara Biotech Recent Development
11.14 Luminous BioSciences
11.14.1 Luminous BioSciences Company Detail
11.14.2 Luminous BioSciences Business Overview
11.14.3 Luminous BioSciences Exosome Platform Introduction
11.14.4 Luminous BioSciences Revenue in Exosome Platform Business (2018-2023)
11.14.5 Luminous BioSciences Recent Development
11.15 Wayen Biotechnologies (Shanghai)
11.15.1 Wayen Biotechnologies (Shanghai) Company Detail
11.15.2 Wayen Biotechnologies (Shanghai) Business Overview
11.15.3 Wayen Biotechnologies (Shanghai) Exosome Platform Introduction
11.15.4 Wayen Biotechnologies (Shanghai) Revenue in Exosome Platform Business (2018-2023)
11.15.5 Wayen Biotechnologies (Shanghai) Recent Development
11.16 Shanghai Yanjiang Biotechnology
11.16.1 Shanghai Yanjiang Biotechnology Company Detail
11.16.2 Shanghai Yanjiang Biotechnology Business Overview
11.16.3 Shanghai Yanjiang Biotechnology Exosome Platform Introduction
11.16.4 Shanghai Yanjiang Biotechnology Revenue in Exosome Platform Business (2018-2023)
11.16.5 Shanghai Yanjiang Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
